Bachem

All eyes on building K

30/07/26 -"Bachem released its 1H26 results on 30 July 2026, delivering a strong operating performance for the half. Margins were affected by higher operating expenses and COGS, as anticipated, with Building ..."

PDF page sample
Pages
58
Language
English
Published on
30/07/26
Download
You may also be interested by these reports :
30/07/26
Ipsen demonstrated robust performance in Q2, exceeding market expectations, which led to an upgraded 2026 guidance. While we may adjust our estimates ...
30/07/26
Bachem released its 1H26 results on 30 July 2026, delivering a strong operating performance for the half. Margins were affected by higher operating ...
29/07/26
The Q2 profitability was somewhat ahead of consensus, and the firm maintained its full-year guidance. Improving profitability and free cash flows, ...
28/07/26
The Q2 results were ahead of expectations, backed by strong growth across GSK’s key focus areas. The management maintained its full-year guidance. ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO